Geratherm Medical Statistics
Want to see DE:GME full AI Analyst Report?
Geratherm Medical (GME) Stock Statistics & Valuation Metrics
Total Valuation
Geratherm Medical has a market cap or net worth of EUR 11.22M. The enterprise value is EUR 7.55M.
- Market Cap
- EUR 11.22M
- Enterprise Value
- EUR 7.55M
Share Statistics
Geratherm Medical has 5,444,998 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 5,444,998
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Geratherm Medical’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is -4.79%.
- Return on Equity (ROE)
- -0.04
- Return on Assets (ROA)
- -0.03
- Return on Invested Capital (ROIC)
- -4.79%
- Return on Capital Employed (ROCE)
- -0.06
- Revenue Per Employee
- 109.30K
- Profits Per Employee
- -6,021.949
- Employee Count
- 136
- Asset Turnover
- 0.57
- Inventory Turnover
- 3.44
Valuation Ratios
The current PE Ratio of Geratherm Medical is -14.76. Geratherm Medical’s PEG ratio is 0.10.
- PE Ratio
- -14.76
- PS Ratio
- 0.76
- PB Ratio
- 0.65
- Price to FCF
- 26.61
- Price to Operating Cash Flow
- 20.40
- PEG Ratio
- 0.10
Income Statement
In the last 12 months, Geratherm Medical had revenue of 14.86M and earned -818.99K in profits. Earnings per share was -0.15.
- Revenue
- 14.86M
- Gross Profit
- 2.37M
- Operating Income
- -1.31M
- Pretax Income
- -906.97K
- Net Income
- -818.99K
- EBITDA
- -154.63K
- Earnings Per Share (EPS)
- -0.15
Cash Flow
In the last 12 months, operating cash flow was 618.00K and capital expenditures -199,000, giving a free cash flow of 419.00K billion.
- Operating Cash Flow
- 618.00K
- Free Cash Flow
- 419.00K
- Free Cash Flow per Share
- 0.07
Dividends & Yields
Geratherm Medical pays an annual dividend of EUR 0.10, resulting in a dividend yield of 4.85%
- Dividend Per Share
- EUR 0.10
- Dividend Yield
- 4.85%
- Payout Ratio
- 27.78%
- Free Cash Flow Yield
- 3.76%
- Earnings Yield
- -6.78%
Stock Price Statistics
- Beta
- 0.52
- 52-Week Price Change
- -36.42%
- 50-Day Moving Average
- 2.22
- 200-Day Moving Average
- 2.53
- Relative Strength Index (RSI)
- 46.70
- Average Volume (3m)
- 1,106
Important Dates
Geratherm Medical upcoming earnings date is Apr 27, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 27, 2026
- Next Earnings Date
- Apr 27, 2027
- Ex-Dividend Date
- Jul 28, 2025
Financial Position
Geratherm Medical as a current ratio of 6.41, with Debt / Equity ratio of 12.60%
- Current Ratio
- 6.41
- Quick Ratio
- 4.99
- Debt to Market Cap
- 0.26
- Net Debt to EBITDA
- 33.19
- Interest Coverage Ratio
- -16.89
Taxes
In the past 12 months, Geratherm Medical has paid -78.58K in taxes.
- Income Tax
- -78.58K
- Effective Tax Rate
- 0.09
Enterprise Valuation
Geratherm Medical EV to EBITDA ratio is 29.83, with an EV/FCF ratio of 15.49.
- EV to Sales
- 0.44
- EV to EBITDA
- 29.83
- EV to Free Cash Flow
- 15.49
- EV to Operating Cash Flow
- 10.50
Balance Sheet
Geratherm Medical has EUR 8.81M in cash and marketable securities with EUR 2.19M in debt, giving a net cash position of EUR 6.62M billion.
- Cash & Marketable Securities
- EUR 8.81M
- Total Debt
- EUR 2.19M
- Net Cash
- EUR 6.62M
- Net Cash Per Share
- EUR 1.22
- Tangible Book Value Per Share
- EUR 2.81
Margins
Gross margin is 66.77%, with operating margin of 13.96%, and net profit margin of -5.81%.
- Gross Margin
- 66.77%
- Operating Margin
- 13.96%
- Pretax Margin
- -6.93%
- Net Profit Margin
- -5.81%
- EBITDA Margin
- 1.48%
- EBIT Margin
- -6.24%
Analyst Forecast
The average price target for Geratherm Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 1.58%
- EPS Growth Forecast
- -148.73%
Scores
- Smart Score
- 3
- AI Score
- 51

